Further, MRS2 is upregulated in multidrug resistant (MDR) gastric cancer (GC) cells, and the higher MRS2 activity is linked with increased resistance to apoptosis (Rawla & Barsouk, 2019). This evidence concerns the gene MRS2 and gastric cancer.